Market Overview:
The global femoral cannula market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cardiovascular diseases and rising demand for minimally invasive surgeries. Additionally, technological advancements in femoral cannulas are also contributing to the growth of the market. Based on type, the global femoral cannula market is segmented into unipolar and bipolar devices. The unipolar devices segment is expected to account for a larger share of the global femoral cannula market than bipolar devices during the forecast period. This can be attributed to their growing popularity among surgeons owing to their ease-of-use and low cost as compared with bipolar devices. Based on application, traditional extracorporeal circulation surgery accounted for a major share of the global femoral cannula market in 2017 owing to its widespread use across various surgical procedures such as coronary artery bypass grafting (CABG) and valve replacement surgeries. However, over time there has been an increase in adoption rates of ECMO systems which are used for providing temporary support for patients with heart or lung failure due cardiac arrest or respiratory failure respectively; this is anticipated drive significant growth in demand for ECMO systems over traditional extracorporeal circulation surgery duringthe forecast period .
Product Definition:
A femoral cannula is a medical device that is inserted into the femoral artery in order to obtain blood samples or to administer fluids or other treatments. The device may also be used to measure blood pressure and heart rate.
Unipolar:
Unipolar is a medical device used for the treatment of cardiac arrest. It's an external defibrillator that uses electrical cardioversion to generate an electric current in the heart muscle, which helps to restart the heart and maintain it until surgical help arrives.
Bipolar:
Bipolar cannula is a medical device used to access the femoral artery and vein. It has two metal blades, which are connected by an insulated electric cable. The bipolar cannula market is expected to witness lucrative growth over the forecast period owing to increasing demand for minimally invasive procedures coupled with technological advancements in this field.
Application Insights:
The traditional extracorporeal circulation surgery segment dominated the global femoral cannula market in terms of revenue share in 2017. This is due to a rise in the adoption of this technology for various cardiovascular procedures such as open heart surgeries, valve replacement and coronary artery bypass grafts. In addition, a rise in healthcare costs has led to an increase in demand for ECMO therapy worldwide. As per data published by ELSO, an estimated 685 patients underwent ECMO therapy across 42 U.S.
ECMO technology offers several benefits including minimal invasive procedure compared to other methods such as cardiopulmonary bypass or cardiac transplantation which have been used traditionally before its introduction thereby contributing towards market growth during traditional cardiovascular procedures globally.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the increasing number of product launches, favorable reimbursement policies, and rising awareness about cardiovascular diseases (CVDs). Moreover, a high prevalence of kidney & heart failure conditions is also expected to drive growth during the forecast period. Europe accounted for a significant share in terms of revenue as well as volume due to growing demand for advanced ECMO products and services along with an increase in CVD cases.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to various factors such as improving healthcare infrastructure & availability of highly skilled physicians & nurses, rise in disposable income levels coupled with growing target population base especially from India and China regions are expected fuel regional demand during the forecast period.
Growth Factors:
- Increasing incidence of chronic diseases: The global femoral cannula market is expected to grow at a CAGR of 5.5% during the forecast period, owing to the increasing incidence of chronic diseases such as cancer, diabetes, and respiratory disorders.
- Technological advancements: The advent of new technologies in the field of medical devices is expected to drive the growth of the femoral cannula market during the forecast period. For instance, in 2017, Cook Medical Inc., introduced a novel product called InVision Elite Femoral Artery Cannula that offers superior performance and safety features compared to traditional products available in the market.
- Rising geriatric population: The global geriatric population is growing at a rapid pace and this is anticipated to drive demand for femoral cannulas over the next few years. Elderly patients are more susceptible to various health conditions that require use of femoral cannulas for treatment or diagnosis purposes.
Scope Of The Report
Report Attributes
Report Details
Report Title
Femoral Cannula Market Research Report
By Type
Unipolar, Bipolar
By Application
Traditional extracorporeal circulation surgery, Extracorporeal membrane oxygenation (ECMO), Hemodialysis, Other
By Companies
Medtronic, Edward Lifescience, LivaNova, Surge Cardiovascular, Changzhou KangXin Medical Instruments Co., Ltd., Chalice Medical Ltd., Xenios AG
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
166
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global Femoral Cannula Market Report Segments:
The global Femoral Cannula market is segmented on the basis of:
Types
Unipolar, Bipolar
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Traditional extracorporeal circulation surgery, Extracorporeal membrane oxygenation (ECMO), Hemodialysis, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Edward Lifescience
- LivaNova
- Surge Cardiovascular
- Changzhou KangXin Medical Instruments Co., Ltd.
- Chalice Medical Ltd.
- Xenios AG
Highlights of The Femoral Cannula Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Unipolar
- Bipolar
- By Application:
- Traditional extracorporeal circulation surgery
- Extracorporeal membrane oxygenation (ECMO)
- Hemodialysis
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Femoral Cannula Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A femoral cannula is a medical device used to measure blood pressure in the lower leg.
Some of the key players operating in the femoral cannula market are Medtronic, Edward Lifescience, LivaNova, Surge Cardiovascular, Changzhou KangXin Medical Instruments Co., Ltd., Chalice Medical Ltd., Xenios AG.
The femoral cannula market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Femoral Cannula Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Femoral Cannula Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Femoral Cannula Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Femoral Cannula Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Femoral Cannula Market Size & Forecast, 2020-2028
4.5.1 Femoral Cannula Market Size and Y-o-Y Growth
4.5.2 Femoral Cannula Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Unipolar
5.2.2 Bipolar
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Traditional extracorporeal circulation surgery
6.2.2 Extracorporeal membrane oxygenation (ECMO)
6.2.3 Hemodialysis
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Femoral Cannula Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Femoral Cannula Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Unipolar
9.6.2 Bipolar
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Traditional extracorporeal circulation surgery
9.10.2 Extracorporeal membrane oxygenation (ECMO)
9.10.3 Hemodialysis
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Unipolar
10.6.2 Bipolar
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Traditional extracorporeal circulation surgery
10.10.2 Extracorporeal membrane oxygenation (ECMO)
10.10.3 Hemodialysis
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Unipolar
11.6.2 Bipolar
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Traditional extracorporeal circulation surgery
11.10.2 Extracorporeal membrane oxygenation (ECMO)
11.10.3 Hemodialysis
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Unipolar
12.6.2 Bipolar
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Traditional extracorporeal circulation surgery
12.10.2 Extracorporeal membrane oxygenation (ECMO)
12.10.3 Hemodialysis
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Unipolar
13.6.2 Bipolar
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Traditional extracorporeal circulation surgery
13.10.2 Extracorporeal membrane oxygenation (ECMO)
13.10.3 Hemodialysis
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Femoral Cannula Market: Competitive Dashboard
14.2 Global Femoral Cannula Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 Edward Lifescience
14.3.3 LivaNova
14.3.4 Surge Cardiovascular
14.3.5 Changzhou KangXin Medical Instruments Co., Ltd.
14.3.6 Chalice Medical Ltd.
14.3.7 Xenios AG
